Buscopan Special Precautions

Tablet: In case severe, unexplained abdominal pain persists or worsens, or occurs together with symptoms like fever, nausea, vomiting, changes in bowel movements, abdominal tenderness, decreased blood pressure, fainting or blood in stool, medical advice should be immediately sought.
Buscopan 10 mg Tablets should be used with caution in conditions characterised by tachycardia such as thyrotoxicosis, cardiac insufficiency or failure and in cardiac surgery where it may further accelerate the heart rate. Due to the risk of anticholinergic complications, caution should be used in patients susceptible to intestinal or urinary outlet obstructions.
Because of the possibility that anticholinergics may reduce sweating, Buscopan should be administered with caution to elevation of intraocular pressure may be produced by the administration of anticholinergic agents such as Buscopan in patients with undiagnosed and therefore untreated narrow angle glaucoma. Therefore, patients should seek urgent ophthalmological advice in case they should develop a painful, red eye with loss of vision whilst or after taking Buscopan. One sugar coated tablet of 10 mg contains 41.2 mg sucrose. Patients with the hereditary condition of fructose intolerance should not take this medicine.
Effects on ability to drive and use machines: No studies on the effects on the ability to drive and use machines have been performed. Because of possible visual accommodation disturbances patients should not drive or operate machinery if affected.
Injection: In case severe, unexplained abdominal pain persists or worsens, or occurs together with symptoms like fever, nausea, vomiting, changes in bowel movements, abdominal tenderness, decreased blood pressure, fainting or blood in stool, appropriate diagnostic measures are needed to investigate the etiology of the symptoms. Because of potential risk of anticholinergic complications, caution should be used in patients prone to narrow angle glaucoma as well as in patients susceptible to intestinal or urinary outlet obstructions and in those inclined to tachyarrhythmia.
Elevation of intraocular pressure may be produced by the administration of anticholinergic agents such as Hyoscine-N-butylbromide (BUSCOPAN) in patients with undiagnosed and therefore untreated narrow angle glaucoma. Therefore, patients should seek urgent ophthalmological advice in case they should develop a painful, red eye with loss of vision after the injection of Hyoscine-N-butylbromide (BUSCOPAN).
After parenteral administration of Hyoscine-N-butylbromide (BUSCOPAN), cases of anaphylaxis including episodes of shock have been observed. As with all drugs causing such reactions, patients receiving Hyoscine-N-butylbromide (BUSCOPAN) by injection should be kept under observation.
Caution is needed in patients with cardiac conditions submitted to parenteral treatment with Buscopan. Monitoring of these patients is advised.
Effects on ability to drive and use machines: No studies on the effects on the ability to drive and use machines have been performed.
Injection: However, patients should be advised that they may experience undesirable effects such as accommodation disorder or dizziness during treatment with Hyoscine-N-butylbromide (BUSCOPAN) ampoules. Therefore, caution should be recommended when driving a car or operating machinery. If patients experience accommodation disorder or dizziness, they should avoid potentially hazardous tasks such as driving or operating machinery.